Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Impact of crosslinking chemistry on corneal tissue regeneration after in situ-forming collagen-hyaluronate matrix therapy
Author Affiliations & Notes
  • Thitima Wungcharoen
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
    Ophthalmology, MedPark Hospital, Bangkok, Thailand
  • Fang Chen
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Youngyoon Amy Seo
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • David Myung
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
    Chemical Engineering, Stanford University, Stanford, California, United States
  • Footnotes
    Commercial Relationships   Thitima Wungcharoen None; Fang Chen None; Youngyoon Amy Seo None; David Myung None
  • Footnotes
    Support  NIH NEI R01 EY033363, NIH NEI K08 EY028176, NEI P30-026877, Research to Prevent Blindness Career Development Award, Stanford SPECTRUM program, and Harrington Discovery Institute Scholar-Innovator Program
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2359. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Thitima Wungcharoen, Fang Chen, Youngyoon Amy Seo, David Myung; Impact of crosslinking chemistry on corneal tissue regeneration after in situ-forming collagen-hyaluronate matrix therapy. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2359.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The shortage of cadaveric donor corneas limits the treatment of corneal blindness worldwide. In situ-forming biomaterial matrices that fill and regenerate corneal defects address this major clinical need. We aimed to compare the in vivo wound healing response of collagen-hyaluronate (HA) hydrogels crosslinked with riboflavin-based photocrosslinking chemistry to those crosslinked with a more specific and light-free crosslinking chemistry in the filling of deep corneal stromal defects in vivo.

Methods : Lamellar stromal defects over a 3.5 mm diameter area in rabbit corneas were filled with collagen-HA hydrogels crosslinked by UVA (365 nm) light exposure and riboflavin as a photosensitizer (photocrosslinked collagen/HA) in 6 eyes and in situ-forming collagen-HA hydrogels crosslinked with bifunctional PEG-succinimide (collagen-PEG/HA) in 6 eyes. Corneal wound healing, thickness, and opacity were evaluated using slit lamp exam, optical coherence tomography (OCT), and pachymetry on days 7,14, and 28.

Results : A 70% ± 5% cut depth was achieved without significant difference between the two groups. At 28 days, overall corneal thickness as well as stromal and epithelial thickness in the corneas treated with collagen-PEG/HA gel were not significantly between the two treatment groups. However, collagen-PEG/HA was found to have restored more than 85% of the stromal and overall thickness which was not statistically significantly different from normal corneas on day 28, whereas the photocrosslinked collagen/HA gel group showed significantly lower stromal and overall thickness compared to normal corneas. There was no statistically significant difference in epithelial healing and corneal opacity between the two groups. The epithelium healed completely in the majority of the eyes within days 14 and in 100% of the eyes healed within days 28.

Conclusions : In-situ forming collagen-PEG/HA gel and photocrosslinked collagen/HA gel promoted corneal stromal thickness restoration and supported epithelial wound healing. Corneas treated with collagen-PEG/HA gel improved corneal thickness restoration to a greater extent than photocrosslinked collagen/HA. Further work is merited to evaluate the potential impact of crosslinking specificity on corneal tissue regeneration after matrix therapy.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×